A study will soon be done to examine the affects of fasting on cholesterol. The WONDERFUL trial, consisting of up to 128 people who are at higher risk for certain chronic diseases, examines LDL cholesterol levels, metabolic issues, and cognitive issues. Researchers conducting the trial are looking for participants between 21-60 years old, and who are not on statin medications or medications for diabetes. Furthermore, they should be pre-diabetic,type 2 diabetes controlled by diet, or the metabolic syndrome.
- Intermountain Medical Center Heart Institute researchers have conducted observational intermittent fasting studies over the last decade
- Among apparently healthy individuals and in people with pre-diabetes, their interventional studies have found powerful biological changes caused by short-term fasting
- Health benefits may also result from fasting because fasting improves an individual’s dietary control.
“This study, named the WONDERFUL Trial, will be the first randomized trial of fasting that uses a control group of people eating their usual diet and that evaluates a single primary outcome that is not weight loss.”